SPRB $15.00 analyst upgrade must read article! (Updated - December 16, 2021 4:07 PM EST) Oppenheimer analyst Hartaj Singh initiates coverage on Spruce Biosciences, Inc. (NASDAQ: SPRB) with a Outperform rating and a price target of $15.00. https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Oppenheimer+Starts+Spruce+Biosciences%2C+Inc.+%28SPRB%29+at+Outperform/19363234.html